Director of Myeloma Immunotherapy
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Philadelphia, Pennsylvania, United States
Dr. Cohen received his medical degree and Internal medicine training from the University of Pennsylvania and completed his Hematology/Medical Oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. Board certified in internal medicine, medical oncology, and hematology, Dr. Cohen is a member of ASH, ASCO, AACR and the International Myeloma Society, and a reviewer for a number of peer-reviewed journals. He has written dozens of original articles, book chapters, and reviews on cancer immunotherapy, multiple myeloma, amyloidosis, and stem cell transplant.
Dr. Cohen is currently Director of Myeloma Immunotherapy and an Associate Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia.
Integrating T cell redirection in frontline MM
Friday, September 29, 2023
9:45 AM – 9:55 AM EEST